Global Clinical Trial Partners chose AG Mednet’s Judi as technology provider

| By | Clinical Trials

Global Clinical Trial Partners (GCTP) has chosen AG Mednet’s Judi as its sole technology provider to deliver its enhanced, rigorous, single-vendor endpoint adjudication services to its clients.

GCTP’s independent adjudication offering focuses on management of clinical event committees (CECs). The company provides endpoint adjudication for clinical trials as well as bespoke clinical trial consultancy, with a team of world-renowned clinical trial experts and academics in concert with pharmaceutical industry experts.

With Judi, GCTP will deliver a robust end-to-end, technologically advanced adjudication solution for clients by implementing their expertise in a concise, reproducible and efficient set of workflow methodologies that have been tried and tested in dozens of projects over more than 25 years.

GCTP (Glasgow, Scotland) works collaboratively with clients to determine an approach that best suits their unique needs and handles development of the endpoint process from start to finish. The company manages all aspects of the CEC process from small, single-center to large multinational, multi-center studies. Specific to adjudication, through Judi, GCTP provides:

  • Endpoint data capture via eCRF
  • Endpoint process management
  • Integration of the CEC process within trial frameworks
  • Overall electronic adjudication system development
  • Adjudication data packet assembly

AG Mednet’s Judi helps advance clinical trials, serving as the first comprehensive electronic endpoint adjudication system to manage workflow and ensure data quality. Judi is an integrated, cloud-based SaaS tool providing a level of flexibility that enables the implementation of the most complex endpoint and adverse event processes, translating into more easily managed projects, fewer queries, higher accountability and increased quality.

AG Mednet is the leading quality compliance partner for image data submission and collection, as well as endpoint adjudication and adverse event adjudication workflows. The company is a leading proponent of zero-delay clinical trials and has supported more than 1,100 global trials.

SOURCE: ag mednet
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.